Pabau Engage inbox

Pabau Engage is here: every patient conversation in one inbox.

Learn more
HCPCS Code

HCPCS code S0126 – Follitropin alfa injection


Code Definition

S0126 is the HCPCS Level II code for an injection of follitropin alfa, 75 IU, billed as one unit for each 75 IU administered.

Follitropin alfa is a recombinant follicle-stimulating hormone (FSH) used for ovarian stimulation, ovulation induction and assisted reproductive technology (ART) cycles. Medicare does not recognize S-codes for payment, and most commercial payers require prior authorization before they process a claim. Most denials trace to a wrong unit count, a missing National Drug Code (NDC) or an absent prior authorization.

Level
Level II
Category
S — Temporary national codes (non-Medicare)
Status
Active code; not payable by Medicare
Billable
No
Code also known as
Gonal-F injection, recombinant FSH injection
Save time. Improve accuracy. Get paid faster.
Automate coding with Pabau

Let Pabau's smart automation suggest the right codes, reduce claim denials, and keep your practice compliant—effortlessly.

  • AI-powered code suggestions
  • Real-time compliance checks
  • Faster claims, fewer denials
Why practices choose Pabau
Save hours every week

Automate repetitive tasks and focus on what matters most—your patients.

Improve accuracy

Reduce coding errors and ensure compliance with the latest regulations.

Get paid faster

Clean claims, fewer denials, and faster reimbursements.

Grow with confidence

Powerful insights and reporting to help your practice thrive.

HIPAA compliant SOC 2 certified GDPR-compliant Trusted by 4,000+ clinics worldwide

Key takeaways

Key takeaways

HCPCS code S0126 reports follitropin alfa injection in 75 IU units, so the unit count is the IU given divided by 75.

Medicare does not recognize S-codes for payment, and most state Medicaid programs exclude fertility drugs, so S0126 is mainly billed to commercial payers.

Most commercial payers require prior authorization for S0126, and a missing or expired authorization is a frequent cause of denials.

Follitropin beta (Follistim AQ) bills under S0128, and swapping the two codes triggers an NDC mismatch denial.

Pabau, the practice management platform we build, tracks the authorization code, dates and sessions on the patient’s case, with a warning when one is missing.

HCPCS code S0126: Definition and official descriptor

HCPCS code S0126 is defined as “Injection, follitropin alfa, 75 IU” in the Centers for Medicare and Medicaid Services (CMS) HCPCS Level II code set. The billing unit is each 75 IU administered. The unit count on the claim line is the number of 75 IU increments the patient received during that encounter.

Follitropin alfa is a biosynthetic (recombinant DNA-derived) form of FSH. It binds FSH receptors in the ovary to stimulate follicular development. The brand most commonly billed under S0126 is Gonal-F, manufactured by EMD Serono. Any FDA-approved follitropin alfa product maps to this code, so confirm the specific NDC for each product dispensed.

FieldValue
HCPCS codeS0126
Official descriptorInjection, follitropin alfa, 75 IU
Code typeHCPCS Level II, S-code (non-Medicare)
Drug classRecombinant follicle-stimulating hormone (r-FSH)
Primary brand nameGonal-F (EMD Serono)
Unit of servicePer 75 IU administered
Medicare coverageNot covered (Medicare does not recognize S-codes for payment)

What S0126 covers and what it excludes

S0126 covers follitropin alfa injections given as part of ovarian stimulation, ovulation induction and IVF protocols. The most frequent scope error is billing a different gonadotropin under this code.

Covered under S0126:

  • Follitropin alfa (Gonal-F) injections for controlled ovarian stimulation in IVF cycles
  • Follitropin alfa for ovulation induction in anovulatory infertility
  • Follitropin alfa for multifollicular development in intrauterine insemination (IUI) protocols

Not covered under S0126:

  • Follitropin beta (use S0128, a different recombinant FSH molecule)
  • Menotropins, urofollitropin, or other gonadotropins (each has its own HCPCS code)
  • Compounded FSH preparations (these are not FDA-approved products and do not map to S0126)
  • Drug dispensing fees or administration fees (bill these on a separate claim line with the appropriate administration code)

Most miscoding on this code comes from mixing up follitropin alfa and follitropin beta. If the physician ordered Follistim AQ (follitropin beta), bill S0128, not S0126. Payer systems flag this mismatch and deny the claim.

How to calculate and report units for HCPCS code S0126

Each unit of S0126 equals 75 IU of follitropin alfa administered. Bill the number of 75 IU increments the patient received in that encounter, not the number of vials opened or the total cycle dose.

IU administeredUnits to billCalculation
75 IU1 unit75 / 75 = 1
150 IU2 units150 / 75 = 2
225 IU3 units225 / 75 = 3
300 IU4 units300 / 75 = 4
450 IU6 units450 / 75 = 6

Partial vials: Most payers expect rounding down to whole 75 IU units. If 100 IU was administered, bill 1 unit (75 IU). Confirm your payer’s wastage and rounding policy before you bill a partial increment.

NDC reporting: Most payers require the National Drug Code on the claim line alongside S0126. Report the 11-digit NDC without dashes, after the N4 qualifier, in the drug field of the CMS-1500 or 837P. Include the NDC quantity and unit of measure (UN for units, ML for milliliters). A missing NDC is one of the top S0126 denial triggers.

Pro Tip

Check payer policy for maximum units edits (MUEs) before submitting large unit counts. CMS does not publish MUEs for S-codes, but commercial payers often cap daily units based on typical stimulation protocols. If you are billing 8 or more units in a single encounter, attach clinical notes showing the prescribed dose.

The two follitropin codes are the most frequently confused in fertility billing. S0126 and S0128 describe chemically distinct recombinant FSH molecules. Billing the wrong code triggers a mismatch denial, because the payer’s system cross-references the NDC against the code.

CodeDrugBrand nameBilling unitMedicare
S0126Follitropin alfaGonal-FPer 75 IUNot covered
S0128Follitropin betaFollistim AQPer 75 IUNot covered

For the procedures in the same cycle, such as egg retrieval and embryo transfer, see the IVF procedure codes that pair with gonadotropin HCPCS codes. The S-code drug line and the CPT procedure line go on the same claim form as separate line items.

Diagnosis codes required when billing S0126

Every S0126 claim line needs a supporting ICD-10-CM diagnosis code that establishes medical necessity. Payers match the diagnosis against the drug to verify that the clinical indication is covered under their fertility benefit.

ICD-10-CM codeDescriptionWhen to use
N97.0Female infertility associated with anovulationOvulation induction cycles
N97.1Female infertility of tubal originIVF cycles for tubal factor
N97.8Female infertility of other originDiminished ovarian reserve, unexplained infertility
N97.9Female infertility, unspecifiedUse when specific etiology is not documented
E28.2Polycystic ovarian syndromePCOS patients receiving ovulation induction
Z31.83Encounter for assisted reproductive fertility procedure cycleUse alongside primary infertility code for ART cycles

Use the most specific N97 subcategory the documentation supports. Payers that apply a diagnosis-to-drug crosswalk reject S0126 paired with an unrelated code. Check your payer’s medical policy for the ICD-10 codes it accepts as covered indications before you submit.

Prior authorization requirements for S0126

Most commercial payers require prior authorization for S0126. Fertility drug benefits are among the most closely managed in employer-sponsored plans. Requirements still vary by payer and plan design, so verify the patient’s plan before assuming PA applies.

Typical PA documentation requirements:

  • Diagnosis of infertility with ICD-10 code and supporting chart notes
  • Documentation of failed or contraindicated prior treatment (e.g. clomiphene citrate trials)
  • Cycle monitoring records (baseline ultrasound, day 3 FSH and estradiol levels)
  • Physician attestation specifying follitropin alfa by name and intended dose range
  • Member’s fertility benefit verification (some plans have lifetime cycle limits)

A medical prior authorization form keeps these items together in one request. Our guide to the prior authorization process covers each step from request to approval.

Medicare: Medicare does not cover S0126 or any fertility drug. S-codes are temporary national codes that Medicare does not recognize for payment. Do not submit S0126 to Medicare Part B or Part D.

Medicaid: Each state sets its own Medicaid coverage for fertility drugs, and most state programs exclude them. About 20 states have fertility insurance mandates, but those laws apply to commercial plans, not Medicaid. Check your state Medicaid agency’s fee schedule and drug policy before billing S0126 to Medicaid.

Payer coverage policies for HCPCS code S0126

Payer typeCoverage statusKey conditions
MedicareNot coveredMedicare does not recognize S-codes for payment and does not cover fertility drugs
MedicaidUsually excludedEach state sets its own fertility-drug coverage; verify the state fee schedule and covered drug list
Commercial (fully insured)Often covered with PAState fertility mandates (about 20 states) apply; PA and an infertility diagnosis are usually required; cycle limits may apply
Self-funded ERISA plansVaries by plan designERISA plans can opt out of state fertility mandates; verify plan documents

ERISA self-funded plans are a frequent source of unexpected denials for fertility practices. These plans are exempt from state insurance mandates, so employers can and do exclude fertility coverage entirely. Confirm the plan type at eligibility verification, not at claim submission.

Common denial reasons for S0126 claims

S0126 claims are denied often because fertility benefits are closely managed and the documentation requirements are exacting. Good denial management strategies for fertility practices start by tracking these seven causes.

Denial reasonCommon remark codeCorrective action
Missing or expired prior authCO-15Obtain PA before service; track expiration dates per payer cycle
Wrong unit count (not in 75 IU increments)CO-4, N362Verify dose in IU; divide by 75 and round down to whole units
Missing NDC on claim lineCO-16, M119Add 11-digit NDC with N4 qualifier, quantity, and unit of measure
Diagnosis does not support drugCO-50, N115Verify payer’s covered-indication list; use most specific N97 subcategory
Follitropin beta billed as S0126CO-4, CO-11Use S0128 for Follistim AQ; NDC mismatch triggers automatic denial
Drug not covered (non-mandate ERISA plan)CO-96, CO-204Verify plan type at eligibility; collect patient financial responsibility upfront
Units exceed payer MUECO-4, CO-151Attach clinical documentation showing prescribed dose; appeal with physician notes

When you see CO-15 on an S0126 remittance, check whether the PA was submitted for the correct date range. Many fertility payers issue PA by cycle, not by calendar quarter, so a PA for one stimulation cycle does not extend to the next. Our reference on medical billing denial codes explains what each code in this table means.

Pro Tip

Run a monthly audit of S0126 claims by denial reason code. If CO-15 (missing or invalid authorization) accounts for more than 20% of your denials, look at scheduling first. The authorization is usually missed there, not in the billing department. Build PA verification into the cycle-start checklist, not the claim-submission checklist.

Five fields on the claim line map to these remark codes, so checking them before submission heads off most of the denials in the table.

Table of the five S0126 claim line fields and their denial codes: HCPCS code S0126 not S0128 (CO-4, CO-11); units equal IU divided by 75 rounded down, 225 IU is 3 units (CO-4, N362); NDC with N4 qualifier (CO-16, M119); diagnosis N97.x or E28.2 plus Z31.83 (CO-50, N115); prior authorization for the cycle (CO-15)
Units are the only field you calculate, which is why a wrong IU count is the easiest S0126 denial to prevent. Remark codes as listed in the denial table above.

Documentation requirements for S0126

Clean S0126 claims depend on chart documentation that matches every field on the claim line. These are the records an auditor expects to find, and the same records a payer will request in a post-payment review.

  • Physician order: Specifies follitropin alfa by name (not “FSH” generically), dose in IU per injection, and intended frequency
  • Cycle monitoring notes: Baseline ultrasound, day 3 hormone levels, and follow-up monitoring results supporting the stimulation protocol
  • Prior auth reference number: Recorded in the chart and on the claim form, matching the payer’s PA on file
  • NDC and lot number: Recorded in the medication administration record for each injection encounter
  • Infertility diagnosis support: Diagnostic workup notes (semen analysis, HSG, ovarian reserve testing) supporting the N97.x or E28.2 code
  • Administered dose in IU: Documented in the nursing or clinical note, recording the dose given rather than the dose prescribed

A structured template for cycle monitoring notes captures these fields at every visit, which lowers the risk of a missing data element on audit. The physician order, NDC and administered dose must all sit in the same encounter note. If one of them is absent, a payer can recoup the payment.

Pabau medical form template builder with an app preview of a patient medical history form
Pabau’s medical form templates let your team build one cycle monitoring note, so each S0126 encounter records the order and the dose given.

How Pabau helps fertility practices bill S0126 cleanly

A fertility practice running several stimulation cycles at once tracks authorizations, doses and NDCs across dozens of encounters. When that tracking lives in spreadsheets and inboxes, an expired authorization often surfaces only when the remittance arrives.

In Pabau’s claims management software, the authorization code, dates and sessions sit on the patient’s case, with a warning when one is missing. US practices send CMS-1500 and 837P claims through Claim.MD, run eligibility checks and receive ERA remittances in the same system.

Pabau claims screen with claims grouped as pending, submitted, processing, paid and error
Pabau’s claims view groups every claim by status, so an S0126 line that comes back with an error is easy to find and correct.

Stock in Pabau carries a batch number and expiry date, and the lot is recorded against the patient and the appointment. Mapping the full medical billing workflow from documentation to adjudication shows where S0126 errors enter. Your team can then check those points before each claim goes out.

Track S0126 authorizations and claims in one place

Pabau tracks the authorization code, dates and sessions on each patient’s case, with a warning when one is missing. See how it works for your practice.

Pabau practice management platform

Conclusion

The S0126 denial that costs least is the one stopped at cycle start. Confirm the plan type and the authorization’s cycle dates before the first injection, and the coverage questions are settled before any drug is given.

After that, hold every claim line to one check. The code is S0126 rather than S0128, the units equal the IU given divided by 75, and the NDC matches the product. The trade-off is a few extra minutes at intake against weeks of appeals and resubmissions.

Book a demo to see how Pabau keeps prior authorization details on each patient’s case for fertility billing teams.

Continue your research

Continue your research

Want the claims process end to end? What is medical billing explains the path from service documentation to payment posting.

Looking for denial recovery strategies? Denial management in healthcare outlines how practices reduce claim rejection rates across drug and procedure codes.

Billing another NDC-driven drug code? HCPCS code J2547 walks through units, NDC reporting and billing for peramivir.

Comparing tools for authorization tracking? Best prior authorization software reviews the platforms practices use to manage PA requests.

Frequently asked questions

What does HCPCS code S0126 cover?

HCPCS code S0126 covers injections of follitropin alfa (recombinant FSH), billed per 75 IU administered, used for ovarian stimulation, ovulation induction, and ART cycles. It does not cover follitropin beta (use S0128), other gonadotropins, or compounded FSH preparations.

How many units do I bill for S0126?

Bill one unit of S0126 for each 75 IU administered. If 225 IU was given, bill 3 units (225 divided by 75). Most payers expect partial doses to be rounded down to whole units, so confirm your payer’s wastage and rounding policy.

Does Medicare cover S0126?

No. S-codes are temporary national codes that Medicare does not recognize for payment, and Medicare does not cover fertility drugs. Do not submit S0126 to Medicare Part B or Part D.

What is the difference between S0126 and S0128?

S0126 is for follitropin alfa (brand: Gonal-F), and S0128 is for follitropin beta (brand: Follistim AQ). They are chemically distinct recombinant FSH molecules. Payers cross-reference the NDC against the code, so the wrong code triggers an automatic denial.

Does S0126 require prior authorization?

Most commercial payers require prior authorization for S0126, though requirements vary by plan. Medicare does not cover the drug at all. Self-funded ERISA plans may exclude fertility benefits entirely, whatever the state mandate says. Always verify the patient’s plan before service.

What are the most common reasons S0126 claims are denied?

The most common causes are a missing or expired prior authorization (CO-15) and a unit count not in 75 IU increments (CO-4). A missing NDC on the claim line (CO-16) is another frequent cause. A diagnosis that does not support the drug (CO-50) and follitropin beta billed under S0126 also trigger denials.

Can S0126 be billed under commercial insurance plans?

Yes, many commercial plans cover S0126, particularly in states with fertility insurance mandates. Fully insured and self-funded ERISA plans follow different rules. Prior authorization is usually required, and cycle or lifetime benefit limits commonly apply.

Tanja Lepcheska
Content Writer

Tanja is a Senior Content Writer who has a skill to turn complex med spa topics into easy, engaging reads that actually make sense. She loves helping clinic owners feel confident about growing their business. When she’s not writing, you’ll probably find her rewatching her favorite romantic movies, working on a new crochet project, or rearranging her home decor “just one more time.”
×